Anhedonia—the loss of pleasure or lack of reactivity to pleasurable stimuli—remains a
formidable treatment challenge across neuropsychiatric disorders. In major depressive …

Background: Artificial intelligence (AI) is giving rise to a revolution in medicine and health
care. Mental health conditions are highly prevalent in many countries, and the COVID-19 …

Artificial intelligence (AI) is a major branch of computer science that is fruitfully used for
analyzing complex medical data and extracting meaningful relationships in datasets, for …

Computational psychiatry is a rapidly growing field attempting to translate advances in
computational neuroscience and machine learning into improved outcomes for patients …

Anhedonia is one of the core symptoms of major depressive disorder (MDD), which is often
inadequately treated by traditional antidepressants. The modern framework of anhedonia …

Deficits in cognition, reward processing, and motor function are clinical features relevant to
both aging and depression. Individuals with late-life depression often show impairment …

Aberrations in how people form expectations about rewards and how they respond to
receiving rewards are thought to underlie major depressive disorder (MDD). However, the …

Findings from behavioral and genetic studies indicate a potential role for the involvement of
brain structures and brain functioning in well-being. We performed a systematic review on …

Dietary interventions for people suffering from major depressive disorder (MDD) are an
ongoing field of research. In this article, we present a comprehensive background for …

Depression is a multifactorial disease with unknown etiology affecting globally. It's the
second most significant reason for infirmity in 2020, affecting about 50 million people …